Literature DB >> 9457113

Cystic fibrosis.

B J Rosenstein1, P L Zeitlin.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9457113     DOI： 10.1016/S0140-6736(97)09174-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  42 in total

Review 1.  Genetics 101: detecting mutations in human genes.

Authors:  Alison Sinclair
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

2.  Analysis of most common CFTR mutations in patients affected by nasal polyps.

Authors:  Marzena Kostuch; Janusz Klatka; Andrzej Semczuk; Jacek Wojcierowski; Lucas Kulczycki; Jan Oleszczuk
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-17       Impact factor: 2.503

3.  Spirometry-related pain and distress in adolescents and young adults with cystic fibrosis: the role of acceptance.

Authors:  Annabelle Casier; Liesbet Goubert; Tine Vervoort; Marleen Theunis; Danielle Huse; Frans De Baets; Dirk Matthys; Geert Crombez
Journal:  Pain Res Manag       Date:  2013-08-28       Impact factor: 3.037

4.  Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.

Authors:  L Saiman; Y Chen; S Tabibi; P San Gabriel; J Zhou; Z Liu; L Lai; S Whittier
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov.

Authors:  Tom Coenye; Johan Goris; Theodore Spilker; Peter Vandamme; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

6.  Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III.

Authors:  Tom Coenye; Theodore Spilker; Alissa Martin; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Eicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cells.

Authors:  Florence Borot; Diane-Lore Vieu; Grazyna Faure; Janine Fritsch; Julien Colas; Sandra Moriceau; Maryvonne Baudouin-Legros; Franck Brouillard; Jesus Ayala-Sanmartin; Lhousseine Touqui; Marc Chanson; Aleksander Edelman; Mario Ollero
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

8.  Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction.

Authors:  Tom Coenye; Peter Vandamme; John J LiPuma
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883

9.  Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France.

Authors:  S Biswas; J-C Dubus; M Reynaud-Gaubert; N Stremler; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-05-30       Impact factor: 3.267

10.  A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients.

Authors:  Ida Chiara Guerrera; Giuseppe Astarita; Jean-Philippe Jais; Dorota Sands; Anna Nowakowska; Julien Colas; Isabelle Sermet-Gaudelus; Martin Schuerenberg; Daniele Piomelli; Aleksander Edelman; Mario Ollero
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.